Melodetta™ 24 Fe adds to growing women’s health line
Bridgewater, NJ (USA), September 28, 2017 – Amneal Pharmaceuticals LLC has launched generic Melodetta™ 24 Fe, its AB-rated therapeutic equivalent for Minastrin® 24 Fe. Both the active tablets (norethindrone acetate and ethinyl estradiol, USP, 1 mg/20 mcg) and non-hormonal ferrous fumarate tablets, 75 mg, can be chewed or swallowed whole. The product comes in a box of three blister packs, each containing 28 tablets.
Manufactured at Amneal’s newly-expanded Brookhaven, NY production facility, Melodetta™ 24 Fe is available to wholesalers, distributors and direct to the trade. It is the 11th product and 8th oral contraceptive to join the company’s growing women’s health product line.
Annual U.S. sales of Minastrin® 24 Fe were approximately $350 million, according to July 2017 QuintilesIMS market data.
Amneal Pharmaceuticals LLC, a privately-held company headquartered in Bridgewater, New Jersey, is one of the largest and the fastest growing generics pharmaceutical manufacturers in the United States. Founded in 2002, Amneal now has more than 5,000 employees in North America, Asia and Europe, working together to bring high-quality affordable medicines to patients worldwide. Amneal has significantly expanded its portfolio of generic products to include complex dosage forms in a broad range of therapeutic areas. For more information, visit www.amneal.com.
All trademarks listed in this release are property of their respective owners.